The paper outlines the current standards for the drug treatment of metastatic breast cancer, which were developed by the expert groups of the Society of Cancer Chemotherapists (RUSSCO) and presented at the International Conference on Breast Cancer on 22–24 Janu- ary 2014. The present guidelines are based on the principles of evidence-based medicine and may serve as a practical guide for on- cologists.
